Observational study on Endometrial Stromal Tumors
Endometrial Stromal Tumors: an Observational Study
This study looks at patients with Endometrial Stromal Tumors to learn more about the tumors and how well different treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | Female |
| Sponsor | Italian Sarcoma Group Research network |
| Locations | 13 sites (Meldola, FC and 12 other locations) |
| Trial ID | NCT02829437 on ClinicalTrials.gov |
What this trial studies
This observational study collects both retrospective and prospective data on patients diagnosed with Endometrial Stromal Tumors (EST) to better understand the tumor's biology, natural history, and the effectiveness of various treatment options. The study involves reviewing patient records and treatment outcomes according to established disease guidelines and local practices. Additionally, a central expert pathologist will confirm the diagnosis to ensure accuracy in the data collected.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with Endometrial Stromal Tumors as per WHO classification.
Not a fit: Patients with diagnoses other than Endometrial Stromal Tumors will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the treatment and management of Endometrial Stromal Tumors, potentially leading to improved patient outcomes.
How similar studies have performed: While this study is observational in nature, similar studies have successfully contributed to the understanding of rare tumors, indicating potential for valuable findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with a diagnosis of Endometrial Stromal Tumor (EST) according to the World Health Organization (WHO) classification 2003 or 2014 * Informed consent signature Exclusion Criteria: * patients with different diagnosis from EST
Where this trial is running
Meldola, FC and 12 other locations
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST — Meldola, Fc, Italy (Not_yet_recruiting)
- Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Mi, Italy (Recruiting)
- Istituto Europeo di Oncologia — Milan, Mi, Italy (Not_yet_recruiting)
- Azienda Ospedaliera Universitaria Paolo Giaccone — Palermo, PA, Italy (Not_yet_recruiting)
- Centro di Riferimento Oncologico di Aviano — Aviano, Pd, Italy (Not_yet_recruiting)
- Istituto Oncologico Veneto — Padova, Pd, Italy (Not_yet_recruiting)
- Fondazione del Piemonte per l'Oncologia IRCC Candiolo — Candiolo, Torino, Italy (Not_yet_recruiting)
- Policlinico S.Orsola Malpighi - Unit of Medical Oncology — Bologna, Italy (Not_yet_recruiting)
- Azienda Ospedaliera Universitaria Careggi — Florence, Italy (Not_yet_recruiting)
- Azienda Ospedaliero-Universitaria Careggi — Florence, Italy (Not_yet_recruiting)
- Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4 — Prato, Italy (Not_yet_recruiting)
- Campus Biomedico — Roma, Italy (Not_yet_recruiting)
- Istituti Fisioterapici Ospitalieri di Roma — Roma, Italy (Not_yet_recruiting)
Study contacts
- Study coordinator: Gianluca Ignazzi, PhD
- Email: gianluca.ignazzi@italiansarcomagroup.org
- Phone: +393335359192
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.